NICHOLAS TOCCI: Open Payments
NPI 1497441307 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 49 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,661 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $241 |
| AstraZeneca Pharmaceuticals LP | 6 | $220 |
| PFIZER INC. | 10 | $143 |
| Lilly USA, LLC | 6 | $96 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Exact Sciences Corporation | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $21 |
Products named: AIRSUPRA, MOUNJARO, NURTEC ODT, Ozempic, JARDIANCE, AREXVY, Wegovy, BREZTRI.
Industry payments across NC — which companies pay providers there.
